Karuna Therapeutics, Inc.

KRTXDelisted Mar 18, 2024

Industry: Pharmaceutical Preparations
SEC CIK: 0001771917

SEC filings (opens in a new tab)

Karuna Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 18, 2024; 328 institutions reported holding it in 13F filings for Q4 2023, worth $12.0B in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Karuna Therapeutics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of KRTX: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Of which not filed for Q4 2021	Q4 2021	Change
Holders	159	1	171	+13
Shares	25.7M	722	29.3M	+3.60M (+14.0%)
Value	$3.13B	$88.0K	$3.83B	+$694.6M (+22.2%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Karuna Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to KRTX in Q4 2021
Institution	Shares	Value	% of portfolio
ARCH Venture Management, LLC	2,912,872	$381.6M	40.37%
Deep Track Capital, LP	130,200	$17.1M	1.26%
Adage Capital Partners GP, L.L.C.	118,594	$15.5M	0.03%
Point72 Asset Management, L.P.	93,097	$12.2M	0.05%
Atika Capital Management LLC	75,000	$9.82M	0.80%
Natixis	33,132	$4.34M	0.01%
Castleark Management LLC	23,950	$3.14M	0.12%
Patient Capital Management, LLC	19,200	$2.52M	1.02%
Polar Asset Management Partners Inc.	14,400	$1.89M	0.02%
Toronto Dominion Bank	12,397	$1.62M	0.00%
Ergoteles LLC	10,946	$1.43M	0.06%
Jane Street Group, LLC	9,358	$1.23M	0.00%
HRT Financial LP	8,499	$1.11M	0.01%
HSBC Holdings PLC	7,286	$954.0K	0.00%
Allspring Global Investments Holdings, LLC	6,310	$826.0K	0.00%
Maven Securities LTD	4,073	$534.0K	0.07%
Dynamic Technology Lab Private Ltd	3,519	$461.0K	0.05%
Renaissance Technologies LLC	3,400	$445.0K	0.00%
Marshall Wace, LLP	3,200	$419.0K	0.00%
L & S Advisors Inc	3,000	$393.0K	0.04%
Exane Derivatives	803	$105.2K	0.03%
Lindbrook Capital, LLC	580	$76.0K	0.01%
Umb Bank N A	550	$72.0K	0.00%
KRS Capital Management, LLC	300	$39.0K	0.03%
EverSource Wealth Advisors, LLC	65	$9.00K	0.00%
Rockefeller Capital Management L.P.	13	$1.00K	0.00%
Covestor Ltd	5	$1.00K	0.00%
Parallel Advisors, LLC	1	$0	0.00%

Sold out (15)

Institutions that held Karuna Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of KRTX in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
First Trust Advisors LP	74,241	$9.08M
Kiwi Wealth Investments Limited Partnership	47,500	$5.81M
D. E. Shaw & Co., Inc.	16,285	$1.99M
Two Sigma Investments, LP	14,700	$1.80M
Temasek Holdings (Private) Ltd	12,844	$1.57M
Tudor Investment Corp Et Al	9,906	$1.21M
Man Group plc	7,372	$902.0K
PDT Partners, LLC	6,391	$782.0K
Avitas Wealth Management LLC	5,936	$726.0K
Blueshift Asset Management, LLC	3,000	$367.0K
OneAscent Wealth Management LLC	1,995	$244.0K
Caption Management, LLC	1,700	$208.0K
Penserra Capital Management LLC	675	$82.0K
O'Shaughnessy Asset Management, LLC	546	$67.0K
Meeder Asset Management Inc	3	$0

Not filed for Q4 2021 yet (1)

Institutions that held Karuna Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KRTX in Q3 2021 that haven't filed for Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
First Mercantile Trust Co	722	$88.0K